Hepatology

Copyright © 2013 American Association for the Study of Liver Diseases

Cover image for Vol. 56 Issue 1

July 2012

Volume 56, Issue 1

Pages 1–397, E1–E25

  1. Editorials

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. Systems biology methods help develop a better understanding of hepatitis C virus–induced liver injury (pages 1–4)

      Ragunath Singaravelu, Neda Nasheri, Allison Sherratt and John Paul Pezacki

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25727

    2. Lost in translation? IL28B's discovery and the journey back to the patient (pages 5–8)

      Paul J. Clark and Andrew J. Muir

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25796

  2. Viral Hepatitis

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. The inhibitors of nucleotide biosynthesis leflunomide, FK778, and mycophenolic acid activate hepatitis B virus replication in vitro (pages 9–16)

      Karin Hoppe-Seyler, Peter Sauer, Claudia Lohrey and Felix Hoppe-Seyler

      Article first published online: 1 JUN 2012 | DOI: 10.1002/hep.25602

    2. Early transcriptional programming links progression to hepatitis C virus–induced severe liver disease in transplant patients (pages 17–27)

      Angela L. Rasmussen, Nicolas Tchitchek, Nathan J. Susnow, Alexei L. Krasnoselsky, Deborah L. Diamond, Matthew M. Yeh, Sean C. Proll, Marcus J. Korth, Kathie-Anne Walters, Sharon Lederer, Anne M. Larson, Robert L. Carithers, Arndt Benecke and Michael G. Katze

      Article first published online: 5 JUN 2012 | DOI: 10.1002/hep.25612

    3. Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus–mediated liver disease posttransplantation (pages 28–38)

      Deborah L. Diamond, Alexei L. Krasnoselsky, Kristin E. Burnum, Matthew E. Monroe, Bobbie-Jo Webb-Robertson, Jason E. McDermott, Matthew M. Yeh, Jose Felipe Golib Dzib, Nathan Susnow, Susan Strom, Sean C. Proll, Sarah E. Belisle, David E. Purdy, Angela L. Rasmussen, Kathie-Anne Walters, Jon M. Jacobs, Marina A. Gritsenko, David G. Camp, Renuka Bhattacharya, James D. Perkins, Robert L. Carithers Jr., Iris W. Liou, Anne M. Larson, Arndt Benecke, Katrina M. Waters, Richard D. Smith and Michael G. Katze

      Article first published online: 24 APR 2012 | DOI: 10.1002/hep.25649

    4. High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients (pages 39–48)

      Caroline Scholtes, Christophe Ramière, Dominique Rainteau, Laure Perrin-Cocon, Claude Wolf, Lydie Humbert, Martine Carreras, Aurélie Guironnet-Paquet, Fabien Zoulim, Ralf Bartenschlager, Vincent Lotteau, Patrice André and Olivier Diaz

      Article first published online: 25 APR 2012 | DOI: 10.1002/hep.25628

    5. Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner (pages 49–56)

      Paul J. Clark, Alexander J. Thompson, David M. Vock, Lisa E. Kratz, Adviye A. Tolun, Andrew J. Muir, John G. McHutchison, Mani Subramanian, David M. Millington, Richard I. Kelley and Keyur Patel

      Article first published online: 5 JUN 2012 | DOI: 10.1002/hep.25631

    6. Major vault protein: A virus-induced host factor against viral replication through the induction of type-I interferon (pages 57–66)

      Shi Liu, Qian Hao, Nanfang Peng, Xin Yue, Yu Wang, Yanni Chen, Jianguo Wu and Ying Zhu

      Article first published online: 1 JUN 2012 | DOI: 10.1002/hep.25642

    7. Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B (pages 67–75)

      Milan J. Sonneveld, Vincent Rijckborst, Stefan Zeuzem, E. Jenny Heathcote, Krzysztof Simon, Hakan Senturk, Suzan D. Pas, Bettina E. Hansen and Harry L.A. Janssen

      Article first published online: 25 APR 2012 | DOI: 10.1002/hep.25636

    8. Hepatitis delta virus infects the cells of hepadnavirus-induced hepatocellular carcinoma in woodchucks (pages 76–85)

      Natalia Freitas, Jessica Salisse, Celso Cunha, Ilia Toshkov, Stephan Menne and Severin O. Gudima

      Article first published online: 25 APR 2012 | DOI: 10.1002/hep.25663

    9. HCV RNA levels in a multiethnic cohort of injection drug users: Human genetic, viral and demographic associations (pages 86–94)

      Lorenzo Uccellini, Fan-Chen Tseng, Alessandro Monaco, Fatma M. Shebl, Ruth Pfeiffer, Myhanh Dotrang, Dianna Buckett, Michael P. Busch, Ena Wang, Brian R. Edlin, Francesco M. Marincola and Thomas R. O'Brien

      Article first published online: 1 JUN 2012 | DOI: 10.1002/hep.25652

  3. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. Cidea promotes hepatic steatosis by sensing dietary fatty acids (pages 95–107)

      Linkang Zhou, Li Xu, Jing Ye, De Li, Wenshan Wang, Xuanhe Li, Lizhen Wu, Hui Wang, Feifei Guan and Peng Li

      Article first published online: 1 JUN 2012 | DOI: 10.1002/hep.25611

    2. Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice (pages 108–117)

      Jiyoung Lee, Sunmi Seok, Pengfei Yu, Kyungsu Kim, Zachary Smith, Marcelo Rivas-Astroza, Sheng Zhong and Jongsook Kim Kemper

      Article first published online: 24 APR 2012 | DOI: 10.1002/hep.25609

    3. Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis (pages 118–129)

      Naoki Tanaka, Tsutomu Matsubara, Kristopher W. Krausz, Andrew D. Patterson and Frank J. Gonzalez

      Article first published online: 6 JUN 2012 | DOI: 10.1002/hep.25630

    4. Interstrain differences in liver injury and one-carbon metabolism in alcohol-fed mice (pages 130–139)

      Masato Tsuchiya, Cheng Ji, Oksana Kosyk, Svitlana Shymonyak, Stepan Melnyk, Hiroshi Kono, Volodymyr Tryndyak, Levan Muskhelishvili, Igor P. Pogribny, Neil Kaplowitz and Ivan Rusyn

      Article first published online: 6 JUN 2012 | DOI: 10.1002/hep.25641

  4. Hepatobiliary Malignancies

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. Hepatocellular carcinoma: Detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients (pages 140–148)

      Mi-Suk Park, Sooah Kim, Jignesh Patel, Cristina H. Hajdu, Richard K. G. Do, Lorenzo Mannelli, James S. Babb and Bachir Taouli

      Article first published online: 18 JUN 2012 | DOI: 10.1002/hep.25681

    2. A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list (pages 149–156)

      Christian Toso, Elise Dupuis-Lozeron, Pietro Majno, Thierry Berney, Norman M. Kneteman, Thomas Perneger, Philippe Morel, Gilles Mentha and Christophe Combescure

      Article first published online: 18 JUN 2012 | DOI: 10.1002/hep.25603

    3. Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: Molecular mechanism of IgG4 reaction in cancer tissue (pages 157–164)

      Kenichi Harada, Shinji Shimoda, Yasushi Kimura, Yasunori Sato, Hiroko Ikeda, Saya Igarashi, Xiang-Shan Ren, Hirohide Sato and Yasuni Nakanuma

      Article first published online: 5 JUN 2012 | DOI: 10.1002/hep.25627

    4. Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression (pages 165–175)

      Maddalena Frau, Maria L. Tomasi, Maria M. Simile, Maria I. Demartis, Fabiana Salis, Gavinella Latte, Diego F. Calvisi, Maria A. Seddaiu, Lucia Daino, Claudio F. Feo, Stefania Brozzetti, Giuliana Solinas, Satoshi Yamashita, Toshikazu Ushijima, Francesco Feo and Rosa M. Pascale

      Article first published online: 5 JUN 2012 | DOI: 10.1002/hep.25643

    5. Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis (pages 176–185)

      Wen-Lung Ma, Cheng-Lung Hsu, Chun-Chieh Yeh, Ming-Heng Wu, Chiung-Kuei Huang, Long-Bin Jeng, Yao-Ching Hung, Tze-Yi Lin, Shuyuan Yeh and Chawnshang Chang

      Article first published online: 5 JUN 2012 | DOI: 10.1002/hep.25644

    6. Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating Glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (pages 186–197)

      Bo Wang, Shu-Hao Hsu, Wendy Frankel, Kalpana Ghoshal and Samson T. Jacob

      Article first published online: 5 JUN 2012 | DOI: 10.1002/hep.25632

  5. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis (pages 198–208)

      Christophe Corpechot, Fabrice Carrat, Armelle Poujol-Robert, Farid Gaouar, Dominique Wendum, Olivier Chazouillères and Raoul Poupon

      Article first published online: 5 JUN 2012 | DOI: 10.1002/hep.25599

    2. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation (pages 209–218)

      Jae-Hwi Jang, Andreas Rickenbacher, Bostjan Humar, Achim Weber, Dimitri Aristotle Raptis, Kuno Lehmann, Bruno Stieger, Wolfgang Moritz, Christopher Soll, Panco Georgiev, David Fischer, Endre Laczko, Rolf Graf and Pierre-Alain Clavien

      Article first published online: 5 JUN 2012 | DOI: 10.1002/hep.25626

    3. Regulatory T cells control the CD8 adaptive immune response at the time of ductal obstruction in experimental biliary atresia (pages 219–227)

      Celine S. Lages, Julia Simmons, Claire A. Chougnet and Alexander G. Miethke

      Article first published online: 6 JUN 2012 | DOI: 10.1002/hep.25662

  6. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis (pages 228–238)

      Nicolás Merchante, Antonio Rivero-Juárez, Francisco Téllez, Dolores Merino, Maria José Ríos-Villegas, Manuel Márquez-Solero, Mohamed Omar, Juan Macías, Ángela Camacho, Montserrat Pérez-Pérez, Jesús Gómez-Mateos, Antonio Rivero and Juan Antonio Pineda, on behalf of the Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI)

      Article first published online: 6 JUN 2012 | DOI: 10.1002/hep.25616

    2. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis (pages 239–247)

      Qing-Bing Wang, Hui Zhu, Hai-Ling Liu and Bei Zhang

      Article first published online: 6 JUN 2012 | DOI: 10.1002/hep.25610

    3. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats (pages 248–258)

      Hui-Chun Huang, Sun-Sang Wang, I-Fang Hsin, Ching-Chih Chang, Fa-Yauh Lee, Han-Chieh Lin, Chiao-Lin Chuang, Jing-Yi Lee, Hsian-Guey Hsieh and Shou-Dong Lee

      Article first published online: 6 JUN 2012 | DOI: 10.1002/hep.25625

  7. Liver Injury/Regeneration

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. Efficient suppression of murine intracellular adhesion molecule-1 using ultrasound-responsive and mannose-modified lipoplexes inhibits acute hepatic inflammation (pages 259–269)

      Keita Un, Shigeru Kawakami, Mitsuru Yoshida, Yuriko Higuchi, Ryo Suzuki, Kazuo Maruyama, Fumiyoshi Yamashita and Mitsuru Hashida

      Article first published online: 6 JUN 2012 | DOI: 10.1002/hep.25607

    2. Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice (pages 270–280)

      Claudia D. Fuchs, Thierry Claudel, Pooja Kumari, Guenter Haemmerle, Marion J. Pollheimer, Tatjana Stojakovic, Hubert Scharnagl, Emina Halilbasic, Judith Gumhold, Dagmar Silbert, Harald Koefeler and Michael Trauner

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25601

    3. Peroxisome proliferator-activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity (pages 281–290)

      Andrew D. Patterson, Yatrik M. Shah, Tsutomu Matsubara, Kristopher W. Krausz and Frank J. Gonzalez

      Article first published online: 6 JUN 2012 | DOI: 10.1002/hep.25645

  8. Liver Biology/Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. Inhibition of hepcidin transcription by growth factors (pages 291–299)

      Julia B. Goodnough, Emilio Ramos, Elizabeta Nemeth and Tomas Ganz

      Article first published online: 18 JUN 2012 | DOI: 10.1002/hep.25615

    2. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis (pages 300–310)

      Ashley M. Lakner, Nury M. Steuerwald, Tracy L. Walling, Sriparna Ghosh, Ting Li, Iain H. McKillop, Mark W. Russo, Herbert L. Bonkovsky and Laura W. Schrum

      Article first published online: 18 JUN 2012 | DOI: 10.1002/hep.25613

    3. Fibronectin is essential for survival but is dispensable for proliferation of hepatocytes in acute liver injury in mice (pages 311–321)

      Kei Moriya, Keiko Sakai, Michel H. Yan and Takao Sakai

      Article first published online: 5 JUN 2012 | DOI: 10.1002/hep.25624

    4. Oxidative stress, Nrf2 and keratin up-regulation associate with Mallory-Denk body formation in mouse erythropoietic protoporphyria (pages 322–331)

      Amika Singla, David S. Moons, Natasha T. Snider, Elizabeth R. Wagenmaker, V. Bernadene Jayasundera and M. Bishr Omary

      Article first published online: 25 APR 2012 | DOI: 10.1002/hep.25664

    5. Comparative proteomic analysis of rat hepatic stellate cell activation: A comprehensive view and suppressed immune response (pages 332–349)

      Juling Ji, Feng Yu, Qiuhong Ji, Zhiyao Li, Kuidong Wang, Jinsheng Zhang, Jinbiao Lu, Li Chen, Qun E, Yaoying Zeng and Yuhua Ji

      Article first published online: 6 JUN 2012 | DOI: 10.1002/hep.25650

    6. 15-deoxy-Δ12,14-prostaglandin J2 reduces recruitment of bone marrow–derived monocyte/macrophages in chronic liver injury in mice (pages 350–360)

      Zhen Han, Tieping Zhu, Xihong Liu, Changyong Li, Shi Yue, Xin Liu, Le Yang, Lin Yang and Liying Li

      Article first published online: 5 JUN 2012 | DOI: 10.1002/hep.25672

  9. Reviews

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. Introduction to the genetics and biology of interleukin-28B (pages 361–366)

      Thomas Urban, Michael R. Charlton and David B. Goldstein

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25794

    2. Clinical utility of interleukin-28B testing in patients with genotype 1 (pages 367–372)

      Michelle Lai and Nezam H. Afdhal

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25793

    3. Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus? (pages 373–381)

      Alexander J. Thompson and John G. McHutchison

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25792

  10. Hepatology Elsewhere

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. An inflammatory proposal for hepatocarcinogenesis (pages 382–384)

      Rachel I. Brody and Neil D. Theise

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25759

    2. Beta-blockers in patients with refractory ascites: To treat or not to treat. That is the question? But, what is the answer? (pages 384–386)

      Mónica Guevara

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25724

    3. When activated oncogene meets immunity: A fight to prevent liver tumor initiation (pages 387–389)

      Jean-Charles Nault, Giuliana Amaddeo and Jessica Zucman-Rossi

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25733

    4. Activated hepatic stellate cells: Negative regulators of hepatocyte proliferation in liver diseases (pages 389–391)

      Chuhan Chung and Yasuko Iwakiri

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25761

  11. Clinical Observations in Hepatology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. You have free access to this content
      Synchronous hepatocellular carcinoma and Castleman's disease: The role of the interleukin-6-signaling pathway (pages 392–393)

      Yun Shin Chun, Julien Calderaro and Jessica Zucman-Rossi

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25857

  12. Correspondence

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. Association between interleukin-28B-related genetic variants and liver histopathology differs between hepatitis C virus genotypes (page 394)

      Karolina Rembeck, Johan Westin, Magnus Lindh, Kristoffer Hellstrand, Gunnar Norkrans and Martin Laging, For the NORDynamIC study group

      Article first published online: 6 JUN 2012 | DOI: 10.1002/hep.25598

    2. Frequent detection of immunoglobulin M anti-herpes simplex viral antibody in patients with primary biliary cirrhosis (page 395)

      Keiichi Fujiwara and Osamu Yokosuka

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25597

    3. Gallbladder polyps in primary sclerosing cholangitis: Indication for early intervention (page 396)

      Christoph Schramm and Ansgar W. Lohse

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25589

    4. Gall bladder polyps in primary sclerosing cholangitis: Adhere to the guidelines (page 396)

      Gregory Gores, Keith D. Lindor and Nataliya Razumilava

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25585

  13. Corrections

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. You have free access to this content
      Corrections (page 397)

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25835

      This article corrects:

      The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis†

      Vol. 55, Issue 5, 1529–1539, Article first published online: 4 APR 2012

    2. You have free access to this content
      Corrections (page 397)

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25836

      This article corrects:

      PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease†‡

      Vol. 52, Issue 3, 904–912, Article first published online: 18 MAY 2010

    3. You have free access to this content
      Corrections (page 397)

      Article first published online: 3 JUL 2012 | DOI: 10.1002/hep.25837

      This article corrects:

      Activation of chemokine and inflammatory cytokine response in hepatitis C virus–infected hepatocytes depends on toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates†‡

      Vol. 55, Issue 3, 666–675, Article first published online: 30 JAN 2012

  14. Special Article

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. Corrections
    15. Special Article
    1. Multisociety sedation curriculum for gastrointestinal endoscopy (pages E1–E25)

      Article first published online: 22 MAY 2012 | DOI: 10.1002/hep.25822

SEARCH

SEARCH BY CITATION